Healthcare

Although the shares recorded a significant move during the session, daily share price movements — even sharp ones — should not automatically be interpreted as a definitive change in a company’s underlyingBusinessperformance without reference to specific company announcements.Equityprices can fluctuate due to company-specific news, …

Clinuvel Pharmaceuticals (ASX:CUV) is balancing a profitable commercial medicine with a wider development programme. Record sales in the December half supported another profit, while higher research, personnel and distribution spending reduced netEarnings. The shares were priced at AUD 9.06, placing the market capitalisation near …

CSL Ltd (ASX:CSL) came under selling pressure after its shares closed at AUD 123.06 on 31 July 2026, representing a 3.81% decline during the trading session. The stock also remains 54.57% lower over the past year, reflecting a significantly different longer-term trend compared with …

The attention has intensified as Telix reframes itself from an imaging specialist into an integrated theranostics company, one that both detects and treats cancer using targeted molecules. Whether that transition reshapes Australia's biotechnology hierarchy, as some observers suggest, will depend on clinical data, regulatory …

Originally incorporated in Australia in 2010 and now run from Bloomington, Minnesota under chief executive Barry Regan, Saluda has retained a distinctly Australian shareholder register and board while building the bulk of its business in the United States. For a company still burning cash …

Investor interest has sharpened through 2026 as Recce advanced two pivotal Phase 3 programs, signed a regional licensing term sheet in the Middle East and expanded collaborations with the United States military — positioning that some commentators have tied to a multibillion-dollar US biodefence …

After years of clinical trials, a European CE Mark and a slow build of overseas hospital accounts, 2026 has delivered a cluster of developments that has drawn traders back to the register. The question for the market is whether these are the foundations of …